Company: DARE
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0001401914-25-000014
Chunk: 40

Company: Dare Bioscience, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 40
---
 to participants until withdrawn or distributed from the 401(k) plan. If a participant contributes 5% or more of their compensation, we match their contribution up to 4% of their annual compensation, subject to statutory limits.

We currently do not have any annuity, pension or deferred compensation plan or other arrangements for our executive officers or any employees.

The following disclosure is provided in response to Item 402(x)(2) of Regulation S-K: During fiscal year 2024, no stock options were awarded to any of our named executive officers during the period beginning four business days before the filing of a periodic report on Form 10-Q or Form 10-K, or the filing or furnishing of a current report on Form 8-K that discloses material nonpublic information (other than a current report on Form 8-K disclosing a material new option award grant under Item 5.02(e) of that form), and ending one business day after the filing or furnishing of such report.

2025 Proxy Statement | Page 27

#### Outstanding Equity Awards at Fiscal Year-End
The following table sets forth information concerning equity awards held by our named executive officers that were outstanding as of December 31, 2024:

|                                                                                                                                                                                                            |     |                  |     | 2024 Outstanding Equity Awards at Fiscal Year-End 
 Option  Awards                                    |        |     |               |        |     |          |       |     |            |
| Name                                                                                                                                                                                                       |     | Date of Grant(1) |     | Number of                                         
 Securities                                        
 Underlying                                        
 Unexercised                                       
 Options                                           
 Exercisable                                       
 (#)                                               |        |     | Number of     
 Securities    
 Underlying    
 Unexercised   
 Options       
 Unexercisable 
 (#)           |        |     | Option   
 Exercise 
 Price    
 ($)      |       |     | Option     
 Expiration 
 Date       |
| Sabrina Martucci Johnson                                                                                                                                                                                   |     | 9/7/2018         |     |                                                   | 16,000 |     |               |      — |     |          | 12.12 |     | 9/7/2028   |
|                                                                                                                                                                                                            |     | 1/29/2019        |     |                                                   | 16,250 |     |               |      — |     |          |  9.11 |     | 1/29/2029  |
|                                                                                                                                                                                                            |     | 3/6/2020